Kerry A. Casey

5.2k total citations · 2 hit papers
31 papers, 3.5k citations indexed

About

Kerry A. Casey is a scholar working on Immunology, Rheumatology and Oncology. According to data from OpenAlex, Kerry A. Casey has authored 31 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 9 papers in Rheumatology and 5 papers in Oncology. Recurrent topics in Kerry A. Casey's work include T-cell and B-cell Immunology (19 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (11 papers). Kerry A. Casey is often cited by papers focused on T-cell and B-cell Immunology (19 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (11 papers). Kerry A. Casey collaborates with scholars based in United States, Japan and Netherlands. Kerry A. Casey's co-authors include Vaiva Vezys, David Masopust, Matthew F. Mescher, Kathryn Fraser, Lalit K. Beura, Jason M. Schenkel, Michael Y. Gerner, Julie Curtsinger, Zhengguo Xiao and Stephen C. Jameson and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Kerry A. Casey

30 papers receiving 3.4k citations

Hit Papers

Normalizing the environment recapitulates adult human imm... 2012 2026 2016 2021 2016 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerry A. Casey United States 18 2.8k 586 566 362 260 31 3.5k
Nathalie Schmitt United States 25 3.3k 1.2× 467 0.8× 469 0.8× 590 1.6× 356 1.4× 42 4.1k
Alexandra Ogilvie Germany 9 2.6k 0.9× 394 0.7× 827 1.5× 302 0.8× 198 0.8× 12 3.4k
Dorothy E. Scott United States 31 2.1k 0.8× 389 0.7× 886 1.6× 663 1.8× 251 1.0× 73 3.7k
Chiara Romagnani Germany 39 4.4k 1.6× 869 1.5× 566 1.0× 616 1.7× 253 1.0× 69 5.3k
James B. Wing Japan 22 2.8k 1.0× 952 1.6× 734 1.3× 229 0.6× 203 0.8× 44 3.9k
Lois L. Cavanagh Australia 24 2.7k 1.0× 613 1.0× 566 1.0× 303 0.8× 144 0.6× 35 3.5k
Guido Sireci Italy 35 2.5k 0.9× 614 1.0× 408 0.7× 584 1.6× 504 1.9× 102 3.7k
Vanja Lazarevic United States 26 1.9k 0.7× 416 0.7× 686 1.2× 464 1.3× 456 1.8× 38 3.0k
Jean‐Jacques Pin France 19 3.2k 1.2× 873 1.5× 694 1.2× 379 1.0× 149 0.6× 37 4.2k
Anthony R. French United States 33 4.3k 1.6× 861 1.5× 696 1.2× 932 2.6× 200 0.8× 66 5.5k

Countries citing papers authored by Kerry A. Casey

Since Specialization
Citations

This map shows the geographic impact of Kerry A. Casey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry A. Casey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry A. Casey more than expected).

Fields of papers citing papers by Kerry A. Casey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry A. Casey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry A. Casey. The network helps show where Kerry A. Casey may publish in the future.

Co-authorship network of co-authors of Kerry A. Casey

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry A. Casey. A scholar is included among the top collaborators of Kerry A. Casey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry A. Casey. Kerry A. Casey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ward, James M., Kakali Sarkar, Adam Schiffenbauer, et al.. (2024). Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis. Arthritis Research & Therapy. 26(1). 196–196.
2.
Segal, Neil H., Eugenia Girda, Davendra Sohal, et al.. (2024). A phase 1/2 study of REGN7075 in combination with cemiplimab (cemi) in patients (pts) with advanced solid tumors: Efficacy and safety results.. Journal of Clinical Oncology. 42(16_suppl). 2503–2503. 5 indexed citations
3.
Ward, James M., Terrance P. OʼHanlon, Michael A. Smith, et al.. (2023). Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis. Arthritis & Rheumatology. 75(11). 2014–2026. 12 indexed citations
4.
Segal, Neil H., Eugenia Girda, Lawrence Fong, et al.. (2023). A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: Trial-in-progress update.. Journal of Clinical Oncology. 41(4_suppl). TPS277–TPS277. 5 indexed citations
5.
Kuiper, Jonas J. W., Sanne Hiddingh, Anna M. Hansen, et al.. (2022). A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis. SHILAP Revista de lepidopterología. 2(3). 100175–100175. 4 indexed citations
6.
Johnson, Melissa M., Nehal J. Lakhani, Eugenia Girda, et al.. (2022). 735 A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: initial dose-escalation results. Regular and Young Investigator Award Abstracts. A767–A768. 2 indexed citations
7.
Smith, Michael A., Chia-Chien Chiang, Kamelia Zerrouki, et al.. (2020). Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus. Scientific Reports. 10(1). 4462–4462. 18 indexed citations
8.
Rahman, Saifur, Divya Sagar, Richard N. Hanna, et al.. (2019). Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 78(7). 957–966. 116 indexed citations
9.
Smith, Michael A., Jill Hénault, Jodi L. Karnell, et al.. (2019). SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus. Scientific Reports. 9(1). 14433–14433. 18 indexed citations
10.
Du, Qun, Jodi L. Karnell, Xiaodong Xiao, et al.. (2019). Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. PLoS ONE. 14(1). e0211236–e0211236. 5 indexed citations
11.
Casey, Kerry A., Xiang Guo, Michael A. Smith, et al.. (2018). Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE. Lupus Science & Medicine. 5(1). e000286–e000286. 54 indexed citations
12.
Beura, Lalit K., Sara E. Hamilton, Kevin Bi, et al.. (2016). Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature. 532(7600). 512–516. 760 indexed citations breakdown →
13.
Hénault, Jill, Jeffrey M. Riggs, Jodi L. Karnell, et al.. (2015). Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nature Immunology. 17(2). 196–203. 126 indexed citations
14.
Casey, Kerry A., Kathryn Fraser, Jason M. Schenkel, et al.. (2012). Antigen-Independent Differentiation and Maintenance of Effector-like Resident Memory T Cells in Tissues. The Journal of Immunology. 188(10). 4866–4875. 511 indexed citations breakdown →
15.
Masopust, David, Daniel Choo, Vaiva Vezys, et al.. (2010). Dynamic T cell migration program provides resident memory within intestinal epithelium. The Journal of Experimental Medicine. 207(3). 553–564. 479 indexed citations
16.
Xiao, Zhengguo, Kerry A. Casey, Stephen C. Jameson, Julie Curtsinger, & Matthew F. Mescher. (2009). Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN. The Journal of Immunology. 182(5). 2786–2794. 169 indexed citations
17.
Gerner, Michael Y., Kerry A. Casey, & Matthew F. Mescher. (2008). Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses. The Journal of Immunology. 181(1). 155–164. 54 indexed citations
18.
Vezys, Vaiva, Andrew J. Yates, Kerry A. Casey, et al.. (2008). Memory CD8 T-cell compartment grows in size with immunological experience. Nature. 457(7226). 196–199. 171 indexed citations
19.
Mescher, Matthew F., et al.. (2007). Molecular basis for checkpoints in the CD8 T cell response: Tolerance versus activation. Seminars in Immunology. 19(3). 153–161. 26 indexed citations
20.
Mescher, Matthew F., Julie Curtsinger, Kerry A. Casey, et al.. (2006). Signals required for programming effector and memory development by CD8+ T cells. Immunological Reviews. 211(1). 81–92. 476 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026